ArticleBritish journal of haematology2026
Marked variation in eligibility criteria across registrational trials for relapsed diffuse large B-cell lymphoma limits applicability to clinical practice.
Elizabeth Goodall et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.